Results 201 to 210 of about 2,947,895 (397)

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, EarlyView.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology

British Journal of Pharmacology, EarlyView.
Theorized mechanism of dopamine homeostasis restoration in the nucleus accumbens core induced by a psychedelic intervention. Abstract Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment‐resistant depression because of their ability to alter consciousness and afflicted cognitive ...
Lucas Wittenkeller, Gary Gudelsky, T. John Winhusen, Davide Amato   +3 more
wiley   +1 more source

Selective serotonin reuptake inhibitors [PDF]

BMJ, 2005
openaire   +3 more sources

A Review of Neonatal Selective Serotonin Reuptake Inhibitor Withdrawal Syndrome. [PDF]

J Pediatr Pharmacol Ther
Mamillapalli L, Lu S, Witkin J, Gavaskar R, Cheng A, McIntyre K, Aboujaoude ER, Gonzalez J, Siu A, Sturgill M.   +9 more
europepmc   +1 more source

Selective serotonin reuptake inhibitor use, age-related neuropathology and cognition in late-life. [PDF]

Psychiatry Res, 2023
Sood A, Wilson RS, Yu L, Wang T, Schneider JA, Honer WG, Bennett DA.   +6 more
europepmc   +1 more source

Pindolol augmentation of selective serotonin reuptake inhibitors: Accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression [PDF]

, 2005
Rebecca Segrave, Pradeep J. Nathan
openalex   +1 more source

3,4‐Methylenedioxymethamphetamine (MDMA) does not induce robust psychomotor activation and 50‐kHz ultrasonic vocalisations in tryptophan hydroxylase 2 (Tph2)‐deficient rats lacking serotonin in the central nervous system

British Journal of Pharmacology, EarlyView.
Background and Purpose 3,4‐Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy, is a psychostimulant with entactogenic properties and known to induce arousal and euphoria. As an amphetamine derivate, MDMA acts on the monoamine systems in the brain and stimulates release of dopamine (DA), noradrenaline (NA) and serotonin (5‐HT), yet their ...
Tianhua Wang, Rainer K. W. Schwarting, Markus Wöhr   +2 more
wiley   +1 more source

Clinical efficacy and effects on hypothalamic-pituitary-adrenal axis function of proscar combined with selective serotonin reuptake inhibitor in post-stroke depression. [PDF]

World J Psychiatry
Xu MY, Lu Y, Shi GM, Yao J, Ding CQ, Zhou RJ.   +5 more
europepmc   +1 more source

Severe alcohol use disorder after initiation of selective serotonin reuptake inhibitor therapy. [PDF]

CMAJ, 2023
Gandhi P, Healy D, Bozinoff N.
europepmc   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source